Sulfonamide-salicylaldehyde imines active against methicillin- and trimethoprim/sulfonamide-resistant Staphylococci

Increasing resistance has resulted in an urgent need for new antimicrobial drugs. A systematic me-too approach was chosen to modify clinically used sulfonamides to obtain their imines. Twenty-five compounds were synthesized and evaluated for their antibacterial activity. The most active compounds we...

Full description

Saved in:
Bibliographic Details
Published inFuture medicinal chemistry Vol. 13; no. 22; pp. 1945 - 1962
Main Authors Krátký, Martin, Konečná, Klára, Janoušek, Jiří, Janďourek, Ondřej, Maixnerová, Jana, Kalivodová, Sára, Trejtnar, František, Vinšová, Jarmila
Format Journal Article
LanguageEnglish
Published England 01.11.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Increasing resistance has resulted in an urgent need for new antimicrobial drugs. A systematic me-too approach was chosen to modify clinically used sulfonamides to obtain their imines. Twenty-five compounds were synthesized and evaluated for their antibacterial activity. The most active compounds were also investigated against methicillin- and trimethoprim/sulfamethoxazole (SMX)-resistant Gram-positive species. shared the highest susceptibility including resistant strains with minimum inhibitory concentrations from 3.91 μM (≥2.39 μg ml ). Crucially, the compounds inhibit MRSA and trimethoprim/SMX-resistant without any cross-resistance. Modification of parent sulfonamides turned a bacteriostatic effect into a bactericidal effect. Toxicity for HepG2 and hemolytic properties were also determined. The presence of a dihalogenated salicylidene moiety is required for optimal activity. Based on toxicity, promising derivatives for further investigation were identified.
ISSN:1756-8919
1756-8927
DOI:10.4155/fmc-2021-0169